iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/17109993
Gadolinium deposition in nephrogenic fibrosing dermopathy - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jan;56(1):27-30.
doi: 10.1016/j.jaad.2006.10.048. Epub 2006 Nov 15.

Gadolinium deposition in nephrogenic fibrosing dermopathy

Affiliations
Review

Gadolinium deposition in nephrogenic fibrosing dermopathy

Alan S Boyd et al. J Am Acad Dermatol. 2007 Jan.

Abstract

There is growing recognition of the association between the use of gadolinium-containing radiocontrast agents for magnetic resonance imaging and the serious dermal and systemic disease nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis (NFD/NSF). The pathogenesis of this entity remains unclear; however, our recent observations suggest a likely mechanism for the initial dermal manifestations of this gadolinium toxicity.

PubMed Disclaimer

Comment in

Similar articles

Cited by

MeSH terms

LinkOut - more resources